Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti® and Rexulti® driven by additional investments
Key highlights Lundbeck's total revenue grew by +14% CER[1](+13% DKK) to DKK 18,537 million in the first nine months of 2025. Growth in the U.S. and Europe was the driver of this strong performance. — United States: DKK 9,955 million (+22% CER; +19% DKK) — Europe: DKK 4,318 million (+13% CER; +13% DKK) — International […]